SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fresenius Kabi Oncology executes SPA with Fresenius Kabi AG

28 Jun 2011 Evaluate

Fresenius Kabi Oncology has finalized and executed the share purchase agreement (SPA) with Fresenius Kabi AG with effect from June 24, 2011. As per the share purchase agreement, Fresenius Kabi Oncology's entire shareholding of 171,400,000 equity shares of GBP 0.10 each in Fresenius Kabi Oncology Plc, UK now stands transferred to Fresenius Kabi AG (Germany) at the book value, which is not less than the fair market value. Subsequent to this disinvestment, the company does not have any other subsidiary.

Earlier, Fresenius Kabi Oncology had received an approval at its board meeting held on May 26, 2011 for disinvestment of its entire shareholding in Fresenius Kabi Oncology Plc, UK - a wholly owned subsidiary of the company to Fresenius Kabi Germany and its affiliates. The agreements would come into effect after obtaining all necessary internal approvals and signing of the same, which can be expected in June 2011.

Fresenius Kabi Oncology is a leading Indian company for cancer research and anticancer products. The company uses the services of Dabur Research Foundation (DRF) for research and development activities. The pharma major market its products in various parts of the world namely Bangladesh, Sri Lanka, Thailand, Philippines, Malaysia, Vietnam, Myanmar, Jordan, Russia, Ukraine, Georgia, Kazakhstan, Uzbekistan, Hungary, Kenya, Nigeria, Ghana, Zimbabwe, Brazil, Venezuela and Mexico, among others.

Peers
Company Name CMP
Sun Pharma Inds. 1873.00
Dr. Reddys Lab 1293.45
Cipla 1317.00
Zydus Lifesciences 945.20
Lupin 2265.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×